4526
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Riken Vitamin Co., Ltd. is a manufacturer and distributor of food ingredients, food additives, and chemical modifiers. The company operates through three main business segments: domestic food, domestic chemicals, and overseas operations. Its product portfolio includes seaweed products, dressings, extracts, seasonings, food-grade modifiers, vitamins, health functional foods, chemical modifiers, and feed additives. Key subsidiaries involved in manufacturing and sales include Riken Foods, Sunny Packaging, Eiken Trading, Kenjodo, RIKEVITA (Malaysia), Tianjin Riken Vita Food, RIKEVITA (Singapore), RIKEVITA Vietnam, RIKEVITA (Thailand), RIKEN VITAMIN Europe, RIKEN VITAMIN USA, Riken Vita Purified Food Industry (Shanghai), Riken Vita Asia, and GUYMON EXTRACTS. The company serves domestic Japanese markets as well as international regions including Southeast Asia, South Asia, Oceania, Europe, Africa, the Middle East, North America, Latin America, China, Taiwan, and South Korea.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Packaged Foods Homepage rikenvitamin.jp
Sector Consumer Defensive IR page rikenvitamin.jp
Tags
food additives, vitamins, seaweed products, dressings, extracts, seasonings, chemical modifiers, feed additives, health functional foods, food ingredients, Riken Foods, Sunny Packaging, Eiken Trading, Kenjodo, RIKEVITA (MALAYSIA) SDN. BHD., Tianjin Riken Vita Food Co. Ltd., RIKEVITA (SINGAPORE) PTE LTD, RIKEVITA VIET NAM CO. LTD., RIKEVITA (THAILAND) CO. LTD., RIKEN VITAMIN EUROPE GmbH, RIKEN VITAMIN USA INC., Riken Vita Purified Food Industry (Shanghai) Co. Ltd., Riken Vita Asia Co. Ltd., GUYMON EXTRACTS INC.
Press page rikenvitamin.jp/news

Metrics

Valuation  
Market cap ¥ 97.028B
Market cap (USD) $ 606.433M
P/E 13.42
PEG 4.29
P/BV 1.15
P/S 0.98
P/OCF 12.14
P/FCF 29.28
Dividend yield 3.5%
Turnover / mcap —
Returns  
ROE 8.7%
ROI 7.8%
ROIC 5.2%
Profit margin 7.3%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 3.1%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 26
Quality score 22.2%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 96.3B 95.582B 91.484B 88.75B 79.231B 77.722B 82.974B 89.024B 89.515B 87.181B 88.072B 85.603B 85.419B 77.568B
Net profit 7.035B 9.388B 8.755B 6.414B 21.582B -1.618B -8.933B 2.623B 4.8B 4.089B 4.107B 3.755B 3.59B 2.406B
Free cash flow 967M 3.08B 7.469B 5.708B 3.463B 3.855B 575M 2.772B 2.756B 5.316B 2.406B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 2.871K 2.42K 2.58K 1.92K 1.645K — 3.507K 3.507K 4.123K 4.02K 2.004K 4.127K 2.356K 2.282K
Price performance 12m 0.19 -0.06 0.34 0.17 — — 0 -0.15 0.03 1.01 -0.51 0.75 0.03 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 22.8B 26.5B 24B 19.5B 18.4B 36.8B 39.3B 45B 42.5B 44B
↳ YoY growth +2.3% +16.0% -9.3% -19.0% -5.2% +99.6% +6.7% +14.6% -5.5% +3.5%
↳ 5y CAGR -3.7% +10.0% +8.2% +13.4% +16.9% +19.0%
Borrowings, current (JPY) 14B 9.46B 9.75B 9.28B 23.9B 3.67B 3.31B 11.9B 3.37B 1.94B
Borrowings, non-current (JPY) 19.2B 17B 15.2B 13.9B 451M 13.9B 11.3B 4.12B 6.54B 5.2B
Cash and deposits (JPY) 18B 15.9B 16.6B 14.5B 19.2B 17.3B 19.2B 23.4B 22.3B 20.1B
Intangible assets (JPY) 774M 701M 656M 667M 681M 698M 645M 976M 980M 1.01B
Net debt (borrowings + leases - cash) (JPY) 15.1B 10.5B 8.41B 8.61B 5.14B 232M -4.6B -7.33B -12.4B -12.9B
Cash flow detail
Operating cash flow (JPY) 8.13B 5.75B 6.69B 5.85B 7.63B 6.82B 7.84B 10.5B 7.89B 5.96B
Purchases of property, plant and equipment (JPY) -2.81B -3B -3.92B -5.28B -3.7B -3.25B -2.11B -2.54B -4.68B -4.86B
Purchases of intangible assets (JPY) -78M -42M -57M -111M -73M -110M -15M -446M -134M -133M
Change in receivables (cash effect) (JPY) -1.29B -3.34B 2.03B 2.82B 1.07B -947M -1.14B -2.69B 1.48B -682M
Change in inventories (cash effect) (JPY) -645M 1.4B -2.55B -2.16B 2.67B -1.43B -2.46B -631M -836M -1.94B
Change in payables (cash effect) (JPY) 41M 1.23B 437M -2.8B -271M 952M 456M 1.38B -1.98B -285M
Dividends paid (cash effect) (JPY) -1.28B -1.07B -1.25B -1.38B -1.41B -1.39B -1.58B -2.19B -2.78B -3.24B
Share buybacks (cash effect) (JPY) -24.4B -299M -173M -1M 0.00 0.00 0.00 -6.36B -1.13B -2B
Interest paid (cash effect) (JPY) -777M -670M -893M -712M -706M -274M -127M -113M -113M -115M
Income taxes paid (cash effect) (JPY) -1.93B -1.91B -2.66B -1.94B -926M -1.91B -327M -1.7B -2.11B -2.84B
Operating cash flow before change in receivables (JPY) 9.41B 9.1B 4.66B 3.03B 6.56B 7.77B 8.98B 13.1B 6.41B 6.65B
Free cash flow (OCF - PPE - intangibles) (JPY) 5.24B 2.71B 2.72B 464M 3.86B 3.46B 5.71B 7.47B 3.08B 967M
Income detail
Research and development expense (JPY) 2.79B 2.9B 2.87B 3.09B 3.09B 2.99B 3.22B 3.32B 3.64B 3.99B
↳ 5y CAGR +3.3% +1.4% +2.2% +2.9% +3.3% +5.2%
Total comprehensive income (JPY) 3.25B 5.34B 2.77B -10.1B 1.3B 21.8B 6.4B 13.8B 6.46B 9.55B
Comprehensive income to owners (JPY) 3.29B 5.32B 2.75B -10.1B 1.26B 21.7B 6.39B 13.8B 6.45B 9.55B
Provision for credit losses (JPY) 121M 337M 881M 103M 44M 508M 0.00 0.00 0.00 10M
Credit cost ratio (credit losses / average receivables) (%) 0.5% 1.4% 3.5% 0.5% 0.2% 1.8% 0.0% 0.0% 0.0% 0.0%
Reported Jun 27, 2017 Jun 26, 2018 Jun 25, 2019 Sep 30, 2020 Jun 22, 2021 Jun 28, 2022 Jun 27, 2023 Jun 25, 2024 Jun 23, 2025 Jun 19, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Riken Vitamin Co., Ltd. (ticker 4526), listed in Japan.

ETFs Holding Riken Vitamin Co., Ltd.

ETF Weight in ETF Shares Market value As of
AVDS 0.02% 2,500 $ 58.995K Nov 16, 2026
DFIS 0.01% 35,000 $ 795.654K Nov 12, 2026
DISV 0.01% 25,100 $ 570.597K Nov 12, 2026
DXIV 0.01% 700 $ 15.913K Nov 12, 2026
DFIC 0.00% 25,100 $ 570.597K Nov 12, 2026
DFAX 0.00% 13,800 $ 313.715K Nov 12, 2026
DFAI 0.00% 14,800 $ 336.448K Nov 12, 2026
AVDE 0.00% 32,900 $ 776.372K Nov 16, 2026